Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-06-12FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) from Sandoz Inc. This action represents a regulato…
-
FDA approval · 2015-06-09FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE — Original Application (KVK-Tech, Inc.)
The FDA approved KVK-Tech's methylphenidate hydrochloride extended-release as a generic drug through an Original ANDA.
-
CLINICAL_TRIALS research · 2015-06-09Clinical Trial Update: A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
A completed clinical study evaluating progression of ADHD drug treatment and associated factors.
-
FDA approval · 2015-06-02FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for methylphenidate from Sandoz Inc.
-
FDA approval · 2015-06-02FDA Approved: GUANFACINE EXTENDED-RELEASE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Guanfacine Extended-Release as an original ANDA for a generic extended-release guanfacine product from Upsher-Smith Laboratorie…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2015-06-02Clinical Trial Update: Resilience for Young People With ADHD - a Randomized Controlled Trial of a Brief Intervention Program. [NA]
ClinicalTrials.gov lists a randomized controlled trial titled 'Resilience for Young People With ADHD' evaluating a brief intervention progra…
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders [Phase 1, Phase 2]
The document reports on a Phase 1/Phase 2 study evaluating collaborative primary care services for children with attention deficit and disru…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Effects Of A Computerized Working Memory Training Program On Attention, Working Memory, And Academics, In Adolescents With Severe ADHD/LD [NA]
A completed clinical trial evaluated a computerized working memory training program aimed at improving attention, working memory, and academ…
-
FDA approval · 2015-05-26FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) from Eli Lilly and Company, indicating an updated appr…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Variance of Video Games Playing Patterns Among Adolescents With Psychiatric Disorders [NA]
Clinical trial NCT01621815, sponsored by Shalvata Mental Health Center, has completed and examined variance in video game playing patterns a…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Supplements and Social Skills Intervention Study [NA]
This clinical trial update reports a completed study evaluating supplements and a social skills intervention for children with conduct disor…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior. [Phase 2]
Phase 2 clinical trial evaluating quetiapine in combination with Concerta for attention-deficit/hyperactivity disorder with aggressive behav…
-
FDA label_change · 2015-05-06FDA Approved: GUANFACINE — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
FDA approved a supplemental application for guanfacine from PuraCap Laboratories dba Blu Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder
A clinical trial evaluating a screening protocol for children and adolescents with attention-deficit/hyperactivity disorder has been termina…
-
CLINICAL_TRIALS research · 2015-05-04Clinical Trial Update: Explore the Association Between Neuropsychological Functions and ADHD Diagnosis and Comorbid Using Longitudinal Study in Preschool Children
A clinical trial update from National Taiwan University Hospital examining how neuropsychological functioning relates to ADHD diagnosis and …
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Psychoeducation for the Parents of Attention Deficit Hyperactivity Disorder (ADHD) Children [NA]
A completed clinical trial evaluating a psychoeducation program for the parents of children with attention-deficit/hyperactivity disorder.
-
CLINICAL_TRIALS withdrawal · 2015-04-28Clinical Trial Update: Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging [Phase 4]
A Phase 4 clinical trial investigating whether functional MRI can predict stimulant treatment response in adults with Attention-deficit/hype…
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental NDA from Prasco Laboratories for a generic mixture of amphetamine salts: dextroamphetamine saccharate, amphetami…
-
FDA approval · 2015-04-17FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) submitted by Sandoz Inc, indicating an approved re…
-
FDA approval · 2015-04-17FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved a supplemental application for the Methylphenidate Transdermal System, a methylphenidate patch, submitted by Padagis US LLC.
-
FDA approval · 2015-04-17FDA Approved: METHYLIN — Supplemental Application (SHIONOGI INC.)
FDA approved a supplemental application for METHYLIN (methylphenidate hydrochloride) filed by Shionogi Inc.
-
FDA approval · 2015-04-17FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) from Amneal Pharmaceuticals LLC.
-
FDA approval · 2015-04-17FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) submitted by Sandoz Inc.
-
FDA approval · 2015-04-17FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2015-04-17FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for dextroamphetamine sulfate submitted by SpecGx LLC.